Regulation of B-cell tolerance and triggering by macrophages and lymphoid dendritic cells
- PMID: 2147917
- DOI: 10.1111/j.1600-065x.1990.tb00571.x
Regulation of B-cell tolerance and triggering by macrophages and lymphoid dendritic cells
Abstract
This review explores the concept that accessory cells differentially regulate immune responses such that tolerance or immunity is induced. Macrophages and lymphoid dendritic cells differentially present hapten-conjugated Ig, antigen-antibody complexes and hapten-modified self such that hapten-specific B-cell development into IgM-secreting cells is blocked or stimulated. The mechanism by which macrophages inhibit B-lymphocyte differentiation is dependent upon an antigen-specific signal and a second nonspecific signal supplied by macrophage-derived E-series PG. In contrast, non PGE-producing lymphoid dendritic cells promoted maturation to IgM PFC by acting as a powerful stimulator of T-lymphocyte IL-2 production. PGE2, but not the structurally similar compound PGF2 alpha, synergized with ligands (e.g. antigen-antibody complexes) which cross-link B-cell sIg or both sIg and Fc receptors to promote hapten-specific unresponsiveness to thymus-independent antigens. Murine B lymphomas were also tested for sensitivity to E- and F-series PG. These cells varied in sensitivity to PGE2 and PGE1 in terms of growth inhibition, suggesting heterogeneity in B-cell PG responsiveness. Interestingly, E-series PG synergized with anti-Ig reagents to kill B lymphomas representative of "immature" normal B cells. In contrast to the effects of PGE on IgM production, we discovered that E-, but not F-series, PG promoted B-cell isotype switching to IgE and IgG1 in the presence of IL-4 and the polyclonal B-cell activator LPS. Other agents which stimulate a cAMP response also promoted isotype switching. These observations indicate that PGE are not obligatory inhibitors of immune responses. Research is in progress to uncover the molecular mechanisms by which PGE are "positive" or "negative" regulators of B lymphocytes.
Similar articles
-
Two signals are required for accessory cells to induce B cell unresponsiveness. Tolerogenic Ig and prostaglandin.J Immunol. 1988 Jul 1;141(1):79-84. J Immunol. 1988. PMID: 2454266
-
Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis.J Immunol. 1990 Oct 15;145(8):2644-51. J Immunol. 1990. PMID: 2170523
-
Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis.J Immunol. 1992 Nov 1;149(9):2984-91. J Immunol. 1992. PMID: 1328389
-
Mucosal immunoregulation: environmental lipopolysaccharide and GALT T lymphocytes regulate the IgA response.Microbiol Immunol. 1984;28(3):261-80. doi: 10.1111/j.1348-0421.1984.tb00679.x. Microbiol Immunol. 1984. PMID: 6234450 Review.
-
Regulation of in vivo immune responses: few principles and much ignorance.Ciba Found Symp. 1986;119:6-24. doi: 10.1002/9780470513286.ch2. Ciba Found Symp. 1986. PMID: 2942370 Review.
Cited by
-
Selenium and selenoproteins in prostanoid metabolism and immunity.Crit Rev Biochem Mol Biol. 2019 Dec;54(6):484-516. doi: 10.1080/10409238.2020.1717430. Epub 2020 Jan 30. Crit Rev Biochem Mol Biol. 2019. PMID: 31996052 Free PMC article. Review.
-
Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages.Immunology. 1995 Mar;84(3):446-52. Immunology. 1995. PMID: 7751029 Free PMC article.
-
Prostanoids as friends, not foes: further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats.Inflammopharmacology. 2005;12(5-6):481-92. doi: 10.1163/156856005774382788. Inflammopharmacology. 2005. PMID: 16259716
-
Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.J Allergy Clin Immunol. 2009 Jun;123(6):1277-86.e5. doi: 10.1016/j.jaci.2009.03.019. Epub 2009 May 8. J Allergy Clin Immunol. 2009. PMID: 19427685 Free PMC article.
-
Exercise-related immune gene signature for hepatocellular carcinoma: machine learning and multi-omics analysis.Front Immunol. 2025 Jun 20;16:1606711. doi: 10.3389/fimmu.2025.1606711. eCollection 2025. Front Immunol. 2025. PMID: 40621461 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous